000779041 000__ 02672cam\a2200505Ii\4500
000779041 001__ 779041
000779041 005__ 20230306142907.0
000779041 006__ m\\\\\o\\d\\\\\\\\
000779041 007__ cr\nn\nnnunnun
000779041 008__ 170116s2017\\\\sz\\\\\\o\\\\\001\0\eng\d
000779041 019__ $$a974651477$$a981817093
000779041 020__ $$a9783319453453$$q(electronic book)
000779041 020__ $$a3319453459$$q(electronic book)
000779041 020__ $$z9783319453446
000779041 0247_ $$a10.1007/978-3-319-45345-3$$2doi
000779041 035__ $$aSP(OCoLC)ocn968705998
000779041 035__ $$aSP(OCoLC)968705998$$z(OCoLC)974651477$$z(OCoLC)981817093
000779041 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dIDEBK$$dEBLCP$$dGW5XE$$dN$T$$dOCLCF$$dUAB$$dNJR$$dYDX$$dOCLCO$$dUPM$$dOCLCO$$dIOG$$dOCLCO
000779041 049__ $$aISEA
000779041 050_4 $$aRC388.5
000779041 08204 $$a616.8/1$$223
000779041 08204 $$a610
000779041 24500 $$aNeuroprotective therapy for stroke and ischemic disease /$$cPaul A. Lapchak, John H. Zhang, editors.
000779041 264_1 $$aCham, Switzerland :$$bSpringer,$$c2017.
000779041 300__ $$a1 online resource.
000779041 336__ $$atext$$btxt$$2rdacontent
000779041 337__ $$acomputer$$bc$$2rdamedia
000779041 338__ $$aonline resource$$bcr$$2rdacarrier
000779041 347__ $$atext file$$bPDF$$2rda
000779041 4901_ $$aSpringer series in translational stroke research,$$x2363-958X
000779041 500__ $$aIncludes index.
000779041 506__ $$aAccess limited to authorized users.
000779041 520__ $$aThis book is a critical and comprehensive look at current state-of-the-art scientific and translational research being conducted internationally, in both academia and industry; it serves to address new ways to provide effective treatment to victims of ischemic and hemorrhagic stroke and other ischemic diseases. Currently, stroke can be successfully treated through the administration of a thrombolytic, but the therapeutic window is short and many patients are not able to receive treatment. Only about 30% of patients are "cured" by available treatments. Divided into five sections, the proposed volume explores historical and novel neuroprotection mechanisms and targets, new and combination therapies, as well as clinical trial design for some of the most recent bench-side research.
000779041 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 24, 2017).
000779041 650_0 $$aCerebrovascular disease$$xPrevention.
000779041 650_0 $$aIschemia.
000779041 650_0 $$aNeuroprotective agents.
000779041 7001_ $$aLapchak, Paul A.,$$eeditor.
000779041 7001_ $$aZhang, J. H.$$q(John H.),$$eeditor.
000779041 77608 $$iPrint version:$$z9783319453446
000779041 830_0 $$aSpringer series in translational stroke research.
000779041 852__ $$bebk
000779041 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-45345-3$$zOnline Access$$91397441.1
000779041 909CO $$ooai:library.usi.edu:779041$$pGLOBAL_SET
000779041 980__ $$aEBOOK
000779041 980__ $$aBIB
000779041 982__ $$aEbook
000779041 983__ $$aOnline
000779041 994__ $$a92$$bISE